Johnson & Johnson decides not to conduct trials in India for its one-shot Covid-19 vaccine

Johnson & Johnson decides not to conduct trials in India for its one-shot Covid-19 vaccine While the US-based pharmaceuticals company had sought approval for conducting bridging trials here, it says it wouldn't have to do that now since India has scrapped that requirement. The company said it is exploring how to accelerate the availability of its vaccine in India. https://ift.tt/eA8V8J

Comments

Popular posts from this blog

SC transfers PIL seeking implementation of law on mental health care to NHRC

Over 9.19 crore hospital admissions facilitated under Ayushman Bharat since 2018

Hospital-insurer conflict: Will latest circular by NMC help in reducing the pain of health insurance policyholders?